Extracellular Hsp90α Clinically Correlates with Tumor Malignancy and Promotes Migration and Invasion in Esophageal Squamous Cell Carcinoma [Retraction]
Wang X, An D, Wang X, Liu X, Li B. Onco Targets Ther. 2019;12:1119– 1128.
The Editor and Publisher of OncoTargets and Therapy wish to retract the published article.
We were notified of potential image duplication in the published article. The issues relate to images shown in Figure 2 and Figure 3:
● Figure 2A ECA109 Panel rHsp90α 0 μg/ml appears to have been duplicated with Figure 2A ECA9706 Panel rHsp90α 0 μg/ml, Figure 2C ECA109 Panel rHsp90α 10 μg/ml and Figure 3C ECA109 Panel Hsp90α Ab 5 μg/ml.
● Figure 2A ECA9706 Panel rHsp90α 10 μg/ml appears to have been duplicated with Figure 3A ECA109 Panel Hsp90α Ab IgG.
The authors responded promptly to our queries but were unable to provide the required raw data for this study. The editor determined that the findings of the study were no longer supported and requested for the article to be retracted. The authors agreed with this decision and wish to apologise for this error.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
This retraction relates to this paper
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]